Profile

Robert J. Stratta, M.D.Wake Forest Baptist Health

Robert J. Stratta, M.D.

Professor,



Clinical Specialties

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: rstratta@wakehealth.edu

Insurance Accepted »

Media Medical Expert »

Education & Training

  • M.D., University of Chicago , 1980
  • B.S., University of Notre Dame , 1976
  • Internship, University of Utah, 1981
  • Residency, University of Utah College of, 1986
  • Fellowship, University of Wisconsin-Madiso, 1988

NPI Number

  • 1346226966
Robert J. Stratta, M.D.Wake Forest Baptist Health

Robert J. Stratta, M.D.

Professor, Surgery, General
Center for Diabetes Research
Institute for Regenerative Medicine
Urology

Contact Information

Department: 336-716-0548

Email: rstratta@wakehealth.edu

Media Medical Expert »

Recent Publications

Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ. Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Clin Transplant. 2014;28(1):16-26.

Al-shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Am J Transplant. 2014;14(Suppl 2):72.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Am J Transplant. 2014;14(Suppl 2):74-75.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Am J Transplant. 2014;14(Suppl 2):74.

Stratta RJ, Farney AC, Rogers J, Orlando G. Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Expert Rev Clin Immunol. 2014;10(1):117-132.

Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Influence of prolonged cold ischemia in the era of marginal donor utilization [abstract]. Am J Transplant. 2014;14(Suppl 2):72.

Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ. Successful unintentional ABO-incompatible renal transplantation: blood group A1B donor into an A2B recipient. Am J Clin Pathol. 2014;141(5):724-726.

Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Lin J. Alemtuzumab vs antithymocyte globulin induction in pediatric renal transplant recipients: our single-center experience with 3 year follow-up [abstract]. Am J Transplant. 2013;13(Suppl 5):448.

Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta RJ. Dual kidney transplants from marginal donors: double or nothing [abstract]. Am J Transplant. 2013;13(Suppl 2):72.

Farooq U, Al-Shraideh Y, Al-Geizawi S, Orlando G, Rogers J, Farney A, Stratta RJ. Effect of donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants [abstract]. Am J Transplant. 2013;13(Suppl 2):73-74.

Farooq U, Farney AC, Rogers J, Orlando G, Al-Shraideh Y, Stratta RJ. A decade of experience with deceased donor kidney transplantation in recipients over age 75 [abstract]. Am J Transplant. 2013;13(Suppl 2):73.

Farooq U, Al-Shraideh Y, Orlando G, Rogers J, Farney A, Stratta RJ. Influence of recipient age on outcomes in paired kidney transplantation [abstract]. Am J Transplant. 2013;13(Suppl 2):74.

Farooq U, Rogers J, Al-Shraideh Y, Orlando G, Farney A, Stratta RJ. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Am J Transplant. 2013;13(Suppl 2):74.

Orlando G, Booth C, Wang Z, Petrosyan A, Ross CL, Iskandar S, Rogers J, Farney AC, Delario G, Stratta RJ, Perin L, Soker S. Discarded kidneys as a platform for renal bioengineering and regeneration investigations [abstract]. Am J Transplant. 2013;13(Suppl 2):78.

Ross CL, Booth C, Sanders B, Babbar P, Bergman C, Soker T, Sittadjody S, Salvatori M, Al-Shraideh Y, Stratta RJ, Orlando G. Regeneration and bioengineering of transplantable abdominal organs: current status and future challenges. Expert Opin Biol Ther. 2013;13(1):103-113.

Stratta RJ. Deceased donor offer: knowing when to say yes [abstract]. Am J Transplant. 2013;13(Suppl 2):58.


Farney AC, Rogers J, Orlando G, al-Geizawi S, Buckley M, Farooq U, al-Shraideh Y, Stratta RJ. Evolving experience using kidneys from deceased donors with terminal acute kidney injury.. J Am Coll Surg. 2013;216(4):645-656.

Orlando G, Bendala JD, Shupe T, Bergman C, Bitar KN, Booth C, Carbone M, Koch KL, Lerut JP, Neuberger JM, Petersen B, Ricordi C, Atala A, Stratta RJ, Soker S. Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut. 2013;62(5):774-786.

Farooq U, Farney A, Rogers J, Orlando G, Al-Shraideh Y, Stratta R. A decade of experience with deceased donor kidney transplantation in recipients over age 75 [abstract]. Am J Transplant. 2013;13(Suppl 5):521.

Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Gautreaux M, Winfrey S, Uloko V, Iskandar S, Brim E, Hairston G, Stratta R. Transplantation of CDC high risk kidneys: a low risk option for a high risk problem [abstract]. Am J Transplant. 2013;13(Suppl 5):403.

Al-shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R. Dual kidney transplants from marginal donors: double or nothing [abstract]. Am J Transplant. 2013;13(Suppl 5):484.

Farooq U, Al-Shraideh Y, Orlando G, Rogers J, Farney A, Stratta R. Influence of recipient age on outcomes in paired kidney transplantation [abstract]. Am J Transplant. 2013;13(Suppl 5):484.

Swords DC, Al-Geizawi SM, Farney AC, Rogers J, Burkart JM, Assimos DG, Stratta RJ. Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Clin Transplant. 2013;27(2):E199-E205.

Mirmalek-Sani SH, Orlando G, McQuilling JP, Pareta R, Mack DL, Salvatori M, Farney AC, Stratta RJ, Atala A, Opara EC, Soker S. Porcine pancreas extracellular matrix as a platform for endocrine pancreas bioengineering. Biomaterials. 2013;34(22):5488-5495.

Reeves-Daniel AM, Farney AC, Fletcher AJ, Assimos D, Westcott C, Rogers J, Stratta RJ, Rocco MV, Freedman BI. Ethnicity, medical insurance, and living kidney donation. Clin Transplant. 2013;27(4):E498-E503.

Orlando G, Booth C, Wang Z, Totonelli G, Ross CL, Moran E, Salvatori M, Maghsoudlou P, Turmaine M, Delario G, Al-Shraideh Y, Farooq U, Farney AC, Rogers J, Iskandar SS, Burns A, Marini FC, De Coppi P, Stratta RJ, Soker S. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials. 2013;34(24):5915-5925.

Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Lin J. Alemtuzumab vs antithymocyte globulin as induction in pediatric renal transplantation [abstract]. Pediatr Transplant. 2013;17(Suppl 1):56-57.

Orlando G, Soker S, Stratta RJ, Atala A. Will regenerative medicine replace transplantation?. Cold Spring Harb Perspect Med. 2013;3(8):a015693.

Orlando G, Soker S, Stratta RJ. Organ bioengineering and regeneration as the new Holy Grail for organ transplantation. Ann Surg. 2013;258(2):221-232.

Rogers J, Farney A, Iskandar S, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Gautreaux M, Stratta RJ. Similar results with solitary pancreas compared to simultaneous kidney-pancreas transplantation in the new millennium [abstract]. Transplantation. 2013;96(6 Suppl):S11.

Stratta RJ, Rogers J, Hart L, Doares W, Kaczmorski S, Reeves-Daniel A, Orlando G, Farooq U, Al-Shraideh Y, Palanisamy A, Iskandar S, Farney A. 5 year results of a prospective randomized single center study of alemtuzumab compared to rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation [abstract]. Transplantation. 2013;96(6 Suppl):S86.

Stratta RJ, Farney A, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Rogers J. Single center analysis of mortality in 202 consecutive pancreas transplants [abstract]. Transplantation. 2013;96(6 Suppl):S87.

Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant. 2012;17(1):87-92.

Orlando G, Mirmalek-Sani SH, Sullivan DC, Farney A, Iskandar S, Abouschwareb T [sic] [Aboushwareb T], Arenas-Herrera J, Ko IK, Agcaoili S, Yoo JJ, Atala A, Stratta RJ, Soker S. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering [abstract]. Am J Transplant. 2012;12(Suppl 2):94.

Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, Figliuzzi M, Holmes JH IV, Koch K, Macchiarini P, Mirmalek Sani S-H, Opara E, Remuzzi A, Rogers J, Saul JM, Seliktar D,. Regenerative medicine as applied to general surgery. Ann Surg. 2012;255(5):867-880.

Chen A, Farney A, Hart L, Doares W, Spainhour L, Kaczmorski S, Stratta R, Rogers J, Lin J-J. Alemtuzumab versus antithymocyte globulin as induction in pediatric renal transplantation: our single-center experience [abstract]. Am J Transplant. 2012;12(Suppl 3):316-317.

Doares W, Chen A, Lin J-J, Hart L, Spainhour L, Kaczmorski S, Rogers J, Stratta R, Farney A. Infectious complications in pediatric renal transplant recipients who received alemtuzumab or rabbit anti-thymocyte globulin induction [abstract]. Am J Transplant. 2012;12(Suppl 3):440-441.

Farney A, Rogers J, Hart L, Doares W, Iskandar S, Orlando G, Adams P, Gautreaux M, Kaczmorski S, Stratta R. Long-term results of a prospective randomized study of alemtuzumab vs rabbit anti-thymocyte globulin induction in kidney and kidney pancreas transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):56.

Kaczmorski S, Doares W, Winfrey S, Uloko V, McArthur M, Reeves-Daniel A, Ghanta M, Rogers J, Farney A, Stratta R. Breakthrough CMV infection rates are similar using low dose vs. standard dose valganciclovir in high risk D+/R- kidney or kidney/pancreas transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):470.

Reeves-Daniel AM, Farney A, Fletcher A, Assimos DG, Westcott CJ, Ghanta M, Stratta RJ, Rogers J, Rocco MV, Freedman BI. Race, insurance status, and living kidney donation [abstract]. Am J Transplant. 2012;12(Suppl 3):332.

Stratta RJ, Farney A, Al-Geizawi S, Orlando G, Rogers J. Lessons learned from a single center experience with 183 donation after cardiac death deceased donor kidney transplants [abstract]. Am J Transplant. 2012;12(Suppl 3):499-500.

Stratta RJ, Farney A, Reeves-Daniel A, Ghanta M, Orlando G, Rogers J. Proportionate nephron mass according to deceased donor category and type of transplant: influence of delayed graft function and acute rejection [abstract]. Am J Transplant. 2012;12(Suppl 3):500.

McArthur MC, Iskandar S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Does alemtuzumab induction and negative flow cytometry crossmatching abrogate the need for early graft biopsies in the setting of delayed graft function? [abstract]. Am J Transplant. 2012;12(Suppl 3):372.

Rogers J, Farney A, Orlando G, Brim E, Hairston G, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Iskandar S, Winfrey S, McArthur MC, Uloko V, Stratta R. Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Am J Transplant. 2012;12(Suppl 3):246-247.

Winfrey SA, Al-Geizawi S, Farney A, Gautreaux M, Doares W, Kaczmorski S, Ghanta M, Reeves-Daniel A, Orlando G, Stratta RJ, Rogers J. Influence of donor and recipient ethnicity on outcomes following deceased donor kidney transplantation [abstract]. Am J Transplant. 2012;12(Suppl 3):524.

Orlando G, Garcia-Arraras JE, Soker T, Booth C, Sanders B, Ross CL, De Coppi P, Farney AC, Rogers J, Stratta RJ. Regeneration and bioengineering of the gastrointestinal tract: current status and future perspectives. Dig Liver Dis. 2012;44(9):714-720.

Orlando G, Farney AC, Iskandar SS, Mirmalek-Sani S-H, Sullivan DC, Moran E, AbouShwareb T, De Coppi P, Wood KJ, Stratta RJ, Atala A, Yoo JJ, Soker S. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg. 2012;256(2):363-370.

Orlando G, Wang Z, Booth C, Ross C, Totonelli G, De Coppi P, Marini F, Atala A, Stratta RJ, Soker S. Production and characterization of human renal and ileal ECM scaffols: the ideal platform for renal and intestinal bioengineering investigations [abstract]. J Tissue Eng Regen Med. 2012;6(Suppl 1):127-128.

Pareta R, Sanders B, Babbar P, Soker T, Booth C, McQuilling J, Sivanandane S, Stratta RJ, Orlando G, Opara EC. Immunoisolation: where regenerative medicine meets solid organ transplantation. Expert Rev Clin Immunol. 2012;8(7):685-692.

Booth C, Soker T, Baptista P, Ross CL, Soker S, Farooq U, Stratta RJ, Orlando G. Liver bioengineering: current status and future perspectives. World J Gastroenterol. 2012;18(47):6926-6934.

Algeizawi S, Farney A, Rogers J, Stratta R. Does keeping deceased donor kidneys on machine perfusion for longer time really help? [abstract]. Am J Transplant. 2011;11(Suppl 1):69.

Algeizawi S, Zuckerman J, Farney A, Rogers J, Stratta R. A single center experience utilizing kidneys from deceased donors with low terminal estimated creatinine clearances [abstract]. Am J Transplant. 2011;11(Suppl 1):73.

Algeizawi S, Farney A, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams P, Stratta R. Experience with deceased donor kidney transplantation in patients over age 70: is rationing justified? [abstract]. Am J Transplant. 2011;11(Suppl 1):74.

Algeizawi S, Farney A, Rogers J, Stratta R. Single center analysis of outcomes in 150 consecutive pancreas transplants according to different definitions of 'success' [abstract]. Am J Transplant. 2011;11(Suppl 1):90.

Orlando G, Stratta RJ, Light J. Pancreas transplantation for type 2 diabetes mellitus. Curr Opin Organ Transplant. 2011;16(1):110-115.

Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant. 2011;25(2):255-264.

Farney AC, Hines MH, al-Geizawi S, Rogers J, Stratta RJ. Lessons learned from a single center's experience with 134 donation after cardiac death donor kidney transplants. J Am Coll Surg. 2011;212(4):440-453.

Fridell JA, Powelson JA, Sanders CE, Ciancio G, Burke GW III, Stratta RJ. Preparation of the pancreas allograft for transplantation. Clin Transplant. 2011;25(2):E103-E112.

Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.

Orlando G, Baptista P, Birchall M, De Coppi P, Farney A, Opara E, Rogers J, Stratta RJ, Atala A, Soker S, et al. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int. 2011;24(3):223-232.

Al-Geizawi S, Farney A, Rogers J, Stratta R. Evolving experience utilizing kidneys from deceased donors with terminal acute kidney injury [abstract]. Am J Transplant. 2011;11(Suppl 2):223.

Algeizawi S, Farney A, Rogers J, Gautreaux M, Doares W, Kaczmorski S, Winfrey S, Ghanta M, Reeves-Daniel A, Adams P, Stratta R. Effect of high donor BMI on short term outcomes in expanded criteria deceased donor kidney transplants (DDKT) [abstract]. Am J Transplant. 2011;11(Suppl 2):228.

Kaczmorski S, Doares W, Al-Geizawi S, Gautreaux M, Reeves-Daniel A, Adams P, Ghanta M, Rogers J, Farney A, Stratta R. Are HIV-positive patients at higher risk for BK viral infection following kidney transplantation? [abstract]. Am J Transplant. 2011;11(Suppl 2):259.

Ghanta M, Russell GB, Farney A, Rogers J, Geizawi SA [sic] [Al-Geizawi S], Doares W, Kaczmorski S, Reeves-Daniels A [sic] [Reeves-Daniel A], Adams P, Stratta RJ. Risk factors for early BK virus nephropathy [abstract]. Am J Transplant. 2011;11(Suppl 2):261.

Gautreaux MD, Kiger DF, Winfrey SC, Farney AF [sic] [Farney AC], Rogers J, Beane KN, Victor B, Stewart JW, Stratta RJ. Incorporating a urinary biomarker assay into clinical laboratory practice [abstract]. Am J Transplant. 2011;11(Suppl 2):270.

Rogers J, Farney A, Al-Geizawi S, Doares W, Kaczmorski S, Winfrey S, Gautreaux M, Hart L, Iskandar S, Adams P, Hairston G, Stratta R. Simultaneous kidney-pancreas transplantation in African-American recipients: alemtuzumab versus rATG induction [abstract]. Am J Transplant. 2011;11(Suppl 2):436.

Doares W, Kaczmorski S, Williamson J, Al-Geizawi S, Gautreux M [sic] [Gautreaux M], Reeves-Daniel A, Adams P, Rogers J, Farney A, Stratta R. Millions of dollars baby: is use of IVIG to prevent rejection in sensitized renal and pancreas transplant recipients effective? [abstract]. Am J Transplant. 2011;11(Suppl 2):450-451.

Rogers J, Iskandar S, Farney A, Al-Geizawi S, Reeves-Daniel A, Ghanta M, Doares W, Kaczmorski S, Gautreaux M, Adams P, Stratta R. Long-term outcomes of solitary pancreas transplantation: do surveillance pancreas biopsies level the playing field? [abstract]. Am J Transplant. 2011;11(Suppl 2):431.

Anderson KT, Hart L, Hairston G, McPherson G, Stratta R, Rogers J, Farney A. Simultaneous kidney pancreas transplant recipients have similar perceived physical health quality of life as non-diabetic kidney transplant recipients at 1 and 2 years [abstract]. Am J Transplant. 2011;11(Suppl 2):434.

Al-Geizawi S, Farney A, Rogers J, Reeves-Daniel A, Ghanta M, Winfrey S, Gautreaux M, Doares W, Kaczmorski S, Adams P, Stratta R, et al. 70 deceased donor kidney transplants in patients over age 70: is 70 the new 50? [abstract]. Am J Transplant. 2011;11(Suppl 2):241.

Orlando G, Wood KJ, Stratta RJ, Yoo JJ, Atala A, Soker S. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91(12):1310-1317.

Rogers J, Farney AC, Al-Geizawi S, Iskandar SS, Doares W, Gautreaux MD, Hart L, Kaczmorski S, Reeves-Daniel A, Winfrey S, Ghanta M, Adams PL, Stratta RJ. Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud. 2011;8(1):17-27.

Drachenberg CB, Torrealba JR, Nankivell BJ, Rangel EB, Bajema IM, Kim DU, Arend L, Bracamonte ER, Iskandar SS, Stratta RJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts--updated Banff grading schema. Am J Transplant. 2011;11(9):1792-1802.

Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ. Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Clin Transplant. 2011;25(4):E437-E446.

Kaczmorski S, Doares W, Winfrey S, Al-Geizawi S, Farney A, Rogers J, Stratta R. Gout and transplantation: new treatment option--same old drug interaction [letter]. Transplantation. 2011;92(3):e13-e14.

Reeves-Daniel A, Bailey A, Assimos D, Westcott C, Adams PL, Hartmann EL, Rogers J, Farney AC, Stratta RJ, Daniel K, Freedman BI. Donor-recipient relationships in African American vs. Caucasian live kidney donors. Clin Transplant. 2011;25(5):E487-E490.

Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state [letter]. Transplantation. 2011;92(8):e36-e38.

Stratta RJ, Pietrangeli C, Baillie GM. Defining the risks for cytomegalovirus infection and disease after solid organ transplantation. Pharmacotherapy. 2010;30(2):144-157.

Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, Russell GB, Stratta RJ, Bleyer AJ. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol. 2010;31(5):375-379.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Al-Gezawi SM, Stratta RJ. Gauging the guess: comparing virtual crossmatching to the real thing [abstract]. Am J Transplant. 2010;10(Suppl 4):190.

Algeizawi SMT, Singh RP, Zuckerman J, Requarth J, Farney AC, Rogers J, Taussig J, Stratta RJ. Allograft nephrectomy following kidney transplantation: experience with pre-operative angiographic kidney embolization [abstract]. Am J Transplant. 2010;10(Suppl 4):251.

Reeves-Daniel AM, Hartmann EL, Bailey A, Westcott C, Assimos DG, Adams PL, Rogers J, Farney A, Stratta RJ, Daniel KR. The effect of donor-recipient relationship on African American and Caucasian live kidney donors [abstract]. Am J Transplant. 2010;10(Suppl 4):274.

Farney AC, Rogers J, Al-Geizawi S, Reeves-Daniel A, Hartmann E, Adams P, Gautreaux M, Winfrey S, Iskandar S, Stratta R, et al. Infection or rejection: chicken or egg? [abstract]. Am J Transplant. 2010;10(Suppl 4):320.

Al-Geizawi S, Hartmann E, Farney A, Rogers J, Reeves-Daniel A, Winfrey S, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. Experience with deceased donor kidney transplantation in patients over age 70: better late than never! [abstract]. Am J Transplant. 2010;10(Suppl 4):335-336.

Algeizawi SMT, Farney AC, Rogers J, Stratta R. Does keeping deceased donor kidneys on pulsatile perfusion for longer time really help? [abstract]. Am J Transplant. 2010;10(Suppl 4):440.

Al-Geizawi S, Zuckerman J, Farney A, Rogers J, Stratta R. A single center experience utilizing kidneys from deceased donors with low terminal estimated creatinine clearances [abstract]. Am J Transplant. 2010;10(Suppl 4):444.

Rogers J, Farney A, Iskandar S, Reeves-Daniel A, Hartmann E, Al-Geizawi S, Winfrey S, Gautreaux M, Adams P, Stratta R, et al. Baseline biopsies of live donor renal allografts: 'you can observe a lot just by watching' [abstract]. Am J Transplant. 2010;10(Suppl 4):535.

Cooper M, Kapur S, Stratta R, D'Alessandro A, Malgaonkar S, Allison A, Russell M, Knectle S. Diannexin, a novel ischemia/reperfusion therapeutic agent, reduces delayed graft function (DGF) in renal transplant recipients from marginal donors [abstract]. Am J Transplant. 2010;10(Suppl 4):83.

Cooper M, Kapur S, Stratta R, D'Alessandro A, Mulgaokar S, Allison A, Russell M, Knechtle S. Urinary IP-10 increase post renal transplant is attenuated by single IVB of diannexin, a novel ischemia reperfusion injury (IRI) therapy [abstract]. Am J Transplant. 2010;10(Suppl 4):292.

Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant. 2010;24(4):433-449.

Reeves-Daniel A, Freedman BI, Assimos D, Hartmann EL, Bleyer A, Adams PL, Westcott C, Stratta RJ, Rogers J, Farney AC, Daniel KR. Short-term renal outcomes in African American and Caucasian donors following live kidney donation. Clin Transplant. 2010;24(5):717-722.

Orlando G, Hematti P, Stratta RJ, Burke GW III, Di Cocco P, Pisani F, Soker S, Wood K. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann Surg. 2010;252(6):915-928.

Hakim NS, Stratta RJ, Gray D, Friend P, Colman A, eds. In: Pancreas, islet and stem cell transplantation for diabetes. 2nd ed. New York: Oxford University Press, USA;2010: .

Fridell JA, Rogers J, Stratta RJ. Donor management and selection in pancreas transplantation In: Hakim NS, Stratta RJ, Gray D, Friend P, Colman A, eds Pancreas, islet and stem cell transplantation for diabetes. 2nd ed. New York: Oxford University Press, USA;2010: 63-84.

Stratta RJ, Zuckerman JM. Quality issues in pancreas transplantation In: Hakim NS, Stratta RJ, Gray D, Friend P, Colman A, eds Pancreas, islet and stem cell transplantation for diabetes. 2nd ed. New York: Oxford University Press, USA;2010: 263-282.

Al-Geizawi SMT, Farney AC, Rogers J, Assimos D, Requarth JA, Doares W, Winfrey S, Stratta RJ. Renal allograft failure due to emphysematous pyelonephritis: successful non-operative management and proposed new classification scheme based on literature review. Transpl Infect Dis. 2010;12(6):543-550.

Shihab F, Stratta R, Olyaei A, Carson R, Pankewycz O, Wiland A, Lake P. Early mycophenolic acid (MPA) dose modifications are associated with compromised graft outcomes: rationale for dose changes and analysis of effects in the Mycophenolic Acid Observational Renal Transplant (MORE) registry [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():MO22.07.

Stratta RJ, Doares W, Farney AC, Rogers J, Hart L. Randomized prospective trial of depleting antibody induction in kidney and pancreas transplantation: infectious complications [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():O17.01.

Stratta RJ, Al-Geizawi S, Hartmann EL, Farney AC, Rogers J, Reeves-Daniel A, Doares W, Winfrey S, Kaczmorski S, Gautreaux M, Iskandar S, Adams PL. Experience with deceased donor kidney transplantation in patients over age 70: better late than never [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.58.

Stratta RJ, Al-Geizawi S, Zuckerman J, Farney AC, Rogers J. Recovered deceased donor kidneys with low estimated terminal creatinine clearance values should not be discarded [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.59.

Stratta RJ, Al-Geizawi S, Farney AC, Rogers J. Lessons learned from a single center experience with 107 donation after cardiac death deceased donor kidney transplants [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():P39.02.

Cooper M, Kapur S, Stratta R, D'Alessandro A, Mulgaonkar S, Allison A, Russell M, Knechtle S. Treatment with Diannexin post-reperfusion decreases DGF and improves GFR in renal transplant recipients of marginal kidney donors [abstract]. In: Abstracts of the XXIII International Congress of The Transplantation Society; 2010 Aug 15-19; Vancouver (Canada). 2010;():O12.03.

Farney AC, Doares W, Kaczmorski S, Rogers J, Stratta RJ. Cost-effective immunosuppressive options for solid organ transplantation: a guide to lower cost for the renal transplant recipient in the USA. Immunotherapy. 2010;2(6):879-888.

Reeves-Daniel A, Adams PL, Daniel K, Assimos D, Westcott C, Alcorn SG, Rogers J, Farney AC, Stratta RJ, Hartmann EL. Impact of race and gender on live kidney donation. Clin Transplant. 2009;23(1):39-46.

Doares W, Ashcraft E, Singh R, Hart L, Farney A, Hartmann E, Reeves-Daniel A, Rogers J, Adams P, Stratta R. Prospective, randomized, single-center trial of alemtuzumab vs. rabbit anti-thymocyte globulin induction in renal and pancreas transplant: infectious complications update [abstract]. Am J Transplant. 2009;9(Suppl 2):282-283.

Gautreaux MD, Kiger DF, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel AM, Stratta RJ. The virtual crossmatch in kidney transplantation: is that your final answer? [abstract]. Am J Transplant. 2009;9(Suppl 2):488.

Hartmann EL, Doares W, Reeves-Daniel A, Rogers J, Singh R, Hart L, Gautreaux M, Stratta RJ, Farney A. Safety and efficacy of lymphocyte-depleting induction therapy in older transplant recipients: should grandpa receive Campath? [abstract]. Am J Transplant. 2009;9(Suppl 2):675.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. Rejection on early surveillance biopsies after renal transplantation: finding snakes in the grass [abstract]. Am J Transplant. 2009;9(Suppl 2):513.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Singh R, Doares W, Gautreaux M, Adams P, Stratta R. What can reperfusion and 1 month surveillance biopsies tell us about early renal allograft function? [abstract]. Am J Transplant. 2009;9(Suppl 2):588.

Singh R, Farney A, Rogers J, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Am J Transplant. 2009;9(Suppl 2):216.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Donor hypertension is the most important pretransplant factor predicting graft loss in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):222-223.

Singh R, Hines M, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P, Stratta R. A single center experience using extracorporeal support in donation after cardiac death donors: improved outcomes for renal and extrarenal transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):234-235.

Singh R, Farney A, Rogers J, Iskandar S, Reeves-Daniel A, Hartmann E, Adams P, Stratta R. Polyoma viral nephropathy--new insights [abstract]. Am J Transplant. 2009;9(Suppl 2):421.

Singh R, Zuckerman J, Farney A, Rogers J, Stratta R. Further expansion of donor organ pool: a single center experience utilizing kidneys from deceased donors with terminal acute renal failure [abstract]. Am J Transplant. 2009;9(Suppl 2):485.

Singh R, Farney A, Iskandar S, Rogers J, Gautreaux M, Hartmann E, Reeves-Daniel A, Adams P, Stratta R. Banff '97 type 2a rejection: the extent of tubulointerstitial inflammation matters [abstract]. Am J Transplant. 2009;9(Suppl 2):509.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Recipient factors affecting outcomes in deceased donor kidney transplantation [abstract]. Am J Transplant. 2009;9(Suppl 2):516.

Singh R, Zuckerman J, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R, et al. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Am J Transplant. 2009;9(Suppl 2):567.

Singh R, Farney A, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta R. Native end stage renal disease due to immune causes adversely influences outcomes in kidney transplantation from donation after brain death standard criteria donors [abstract]. Am J Transplant. 2009;9(Suppl 2):683-684.

Zuckerman JM, Singh RP, Farney AC, Rogers J, Hines MH, Stratta RJ. Successful kidney transplantation from a donation after cardiac death donor with acute renal failure and bowel infarction using extracorporeal support. Transpl Int. 2009;22(8):798-804.

Farney AC, Rogers J, Singh R, Hartmann E, Hart L, Reeves-Daniel A, Gautreaux M, Iskandar SS, Adams PL, Stratta RJ, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009;88(6):810-819.

Freedman BI, Nagaraj SK, Lin JJ, Gautreaux MD, Bowden DW, Iskandar SS, Stratta RJ, Rogers J, Hartmann EL, Farney AC, Reeves-Daniel AM. Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation. Am J Transplant. 2009;9(10):2435-2440.

Stratta R, Singh R, Farney A, Rogers J, Doares W, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P. A randomized, prospective trial of alemtuzumab versus rabbit anti-thymocyte globulin induction in kidney-pancreas transplantation: a single center experience [abstract]. Transpl Int. 2009;22(Suppl 2):76-77.

Stratta R, Singh R, Hines M, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Kiger D, Iskandar S, Adams P. A single center experience using extracorporeal support in donation after cardiac death donors [abstract]. Transpl Int. 2009;22(Suppl 2):102.

Stratta R, Singh R, Zuckerman J, Farney A, Rogers J. A single center experience utilizing kidneys from deceased donors with terminal acute renal failure [abstract]. Transpl Int. 2009;22(Suppl 2):191.

Stratta R, Singh R, Zuckerman J, Farney A, Rogers J, Hartman E [sic] [Hartmann E], Reeves-Daniel A, Gautreaux M, Iskandar S, Hairston G, Adams P. A seven year experience with 222 expanded criteria donor kidney transplants at a single center [abstract]. Transpl Int. 2009;22(Suppl 2):191.

Stratta RJ, Farney AC, Rogers J. Import pancreas allografts: good from far or far from good? [editorial commentary]. Transplantation. 2009;88(5):622-623.

Zuckerman JM, Singh RP, Farney AC, Rogers J, Stratta RJ. Single center experience transplanting kidneys from deceased donors with terminal acute renal failure. Surgery. 2009;146(4):686-695.

Stratta R. Pancreatic transplantation for patients with T2D and ESRD [abstract]. Xenotransplantation. 2009;16(5):304-305.

Gautreaux M, Kiger D, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Stratta R. The virtual crossmatch in kidney transplantation: psychic or psychotic? [abstract]. Hum Immunol. 2009;70(Suppl 1):S20.

Freedman BI, Shihabi ZK, Andries L, Spainhour M, Byers JR, Russell GB, Stratta RJ, Calles J, Bleyer AJ. Accuracy of the glycated albumin (GA) and hemoglobin (Hb) A1c assays in diabetic subjects with advanced chronic kidney disease (CKD) [abstract]. J Am Soc Nephrol. 2009;20(Renal Week 2009 Abstract Issue):424A.

Farney A, Sundberg A, Moore P, Hartmann E, Rogers J, Doares W, Jarrett A, Adams P, Stratta R. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation. Clin Transplant. 2008;22(1):41-49.

Singh RP, Stratta RJ. Advances in immunosuppression for pancreas transplantation. Curr Opin Organ Transplant. 2008;13(1):79-84.

Singh RP, Farney AC, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann EL, Reeves-Daniel A, Adams PL, Stratta RJ. Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc. 2008;40(2):506-509.

Singh RP, Rogers J, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ. Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation?. Transplant Proc. 2008;40(2):510-512.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc. 2008;40(2):502-505.

Farney AC, Singh RP, Hines MH, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg. 2008;206(5):1028-1037.

Drachenberg CB, Odorico J, Demetris AJ, Arend L, Bajema IM, Bruijn JA, Cantarovich D, Cathro HP, Iskandar SS, Stratta R, et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant. 2008;8(6):1237-1249.

Gautreaux MD, Rebellato LM, Kiger DF, Haisch CE, Stratta RJ. Cytokine gene polymorphisms in caucasian and African American renal allograft recipients--a multi-year follow-up [abstract]. Am J Transplant. 2008;8(Suppl 2):350.

Reeves-Daniel A, Daniel K, Assimos D, Westcott C, Rogers J, Farney A, Stratta R, Hartmann E, Adams P, Bleyer A, Freedman B. Similar short-term renal outcomes among African Americans and caucasians following live kidney donation [abstract]. Am J Transplant. 2008;8(Suppl 2):191.

Rogers J, Pomper G, Singh R, Farney A, Hartmann E, Reeves-Daniel A, Iskandar S, Gautreaux M, Adams P, Stratta R, et al. Blood transfusion after renal transplantation is associated with inferior early outcome [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Farney A, Rogers J, Zuckerman JM, Gautreaux M, Iskandar S, Adams P, Stratta R. Impact of native end stage renal disease on kidney allograft outcomes: rejection or infection? A multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):351.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL, Stratta RJ. Expanded versus standard criteria donors in kidney transplantation: does donor and recipient age-matching make a difference? [abstract]. Am J Transplant. 2008;8(Suppl 2):368-369.

Singh RP, Zuckerman JM, Farney A, Rogers J, Hartmann E, Gautreaux M, Reeves-Daniel A, Iskandar S, Adams P, Stratta R. Lack of impact of delayed graft function on post-transplant outcomes in kidney transplantation from donation after cardiac death donors [abstract]. Am J Transplant. 2008;8(Suppl 2):369.

Singh RP, Gautreaux MD, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Kiger DF, Iskandar SS, Adams PL, Stratta RJ. Should kidneys from zero-antigen mismatch expanded criteria donors be shared? [abstract]. Am J Transplant. 2008;8(Suppl 2):392.

Singh RP, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Zuckerman JM, Iskandar SS, Adams PL, Stratta RJ. Multivariate analysis of risk factors for acute rejection and kidney allograft loss according to recipient age [abstract]. Am J Transplant. 2008;8(Suppl 2):522.

Singh RP, Farney A, Rogers J, Ashcraft E, Doares W, Hartmann E, Reeves-Daniel A, Gautreaux M, Adams P, Stratta R. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):556.

Singh RP, Farney A, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann E, Reeves-Daniel A, Adams P, Stratta R. Natural history of bacterial infection after enteric exocrine and portal venous drainage of pancreas allografts [abstract]. Am J Transplant. 2008;8(Suppl 2):556.

Singh RP, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Risk factors for graft loss in expanded versus standard criteria kidneys: a multivariate analysis [abstract]. Am J Transplant. 2008;8(Suppl 2):600.

Stratta RJ, Farney AC, Rogers J, Singh RP, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Experience with extended donors and recipients in simultaneous kidney-pancreas transplantation [abstract]. Am J Transplant. 2008;8(Suppl 2):200.

Stratta RJ, Singh RP, Farney AC, Rogers J, Hines MH, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Single center experience in kidney and kidney-pancreas transplantation with donation after cardiac death donors with selective use of extracorporeal support [abstract]. Am J Transplant. 2008;8(Suppl 2):367.

Hartmann EL, Ratliff H, Ashcraft E, Reeves-Daniel A, Farney AC, Rogers J, Stratta RJ, Russell GB. Renal outcomes in older recipients of expanded and standard criteria deceased donor kidney transplants [abstract]. J Am Soc Nephrol. 2008;19():686A.

Hartmann EL, Gatesman M, Roskopf-Somerville J, Stratta R, Farney A, Sundberg A. Management of leukopenia in kidney and pancreas transplant recipients. Clin Transplant. 2008;22(6):822-828.

Hartmann E, Reeves-Daniel A, Singh R, Stratta RJ. Aging kidney donors and recipients: risks and challenges. Aging Health. 2008;4(5):535-541.

Singh RP, Stratta RJ. Current immunosuppression in pancreas transplantation [newsletter article]. Healthc Bull. 2008;2008():.

Cartwright MS, Moore PS, Donofrio PD, Iskandar SS, Stratta RJ. Acute sensory neuropathy associated with rabbit antithymocyte globulin. Am J Transplant. 2007;7(2):484-486.

Stratta RJ, Moore PS, Farney AC, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux MD, Iskandar SS, Adams PL. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204(5):873-884.

Hartmann E, Stratta R, Ashcraft E, Reeves-Daniel A, Doares W, Moore P, Hart L, Sundberg A, Rogers J, Farney A. Short term outcomes in transplant recipients over age 60 randomized to either campath or thymoglobulin induction therapy [abstract]. Am J Transplant. 2007;7(Suppl 2):523.

Jarrett A, Svejkovsky L, Doares W, Ashcraft E, Farney A, Hartman [sic] E [Hartmann E], Rogers J, Adams P, Stratta R. Influence of a pharmacy-based transplant patient medication assistance program on length of stay (LOS), re-admissions, and costs [abstract]. Am J Transplant. 2007;7(Suppl 2):396.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Rogers J, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Doares W, Ashcraft E, Gautreaux M, Adams P, Stratta R. Surveillance pancreas biopsies in solitary pancreas transplantation: a shot in the dark? [abstract]. Am J Transplant. 2007;7(Suppl 2):251.

Ashcraft E, Farney A, Moore P, Hartmann E, Rogers J, Doares W, Hart L, Adams P, Stratta R. A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications [abstract]. Am J Transplant. 2007;7(Suppl 2):234.

Farney A, Rogers J, Ashcroft E, Hartmann E, Hart L, Doares W, Moore P, Jarrett A, Sundberg A, Adams P, Stratta R. Alemtuzumab versus rabbit antithymocyte globulin induction in kidney and pancreas transplantation: a prospective randomized study [abstract]. Am J Transplant. 2007;7(Suppl 2):233.

Reeves-Daniel A, Daniel K, Alcorn S, Farney A, Rogers J, Wescott C, Assimos D, Stratta R, Adams P, Hartmann E. Impact of ethnicity on living kidney donation [abstract]. Am J Transplant. 2007;7(Suppl 2):218.

Gautreaux MD, Kiger DF, Robinson DL, Reeves-Daniel AM, Adams PL, Hartmann EL, Farney AC, Rogers J, Stratta RJ. A positive T-Cell flow cytometric crossmatch may not be a contraindication to renal transplant [abstract]. Am J Transplant. 2007;7(Suppl 2):289.

Moore PS, Farney AC, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007;83(12):1551-1556.

Rogers J, Stratta RJ. The metabolic syndrome as a risk factor in simultaneous kidney-pancreas transplantation. Nat Clin Pract Endocrinol Metab. 2007;3(7):498-499.

Farney AC, Singh RP, Rogers J, Ashcraft E, Doares W, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Experience with alemtuzumab versus rabbit anti-thymocyte globulin induction in pancreas transplantation [abstract]. Xenotransplantation. 2007;14(5):382.

Farney AC, Singh RP, Moore PS, Rogers J, Hartmann EL, Reeves-Daniel A, Gautreaux M, Adams PL, Stratta RJ. Does recipient age influence outcomes in pancreatic transplantation? [abstract]. Xenotransplantation. 2007;14(5):522.

Rogers J, Singh R, Iskandar S, Farney A, Hartmann E, Reeves-Daniel A, Doares W, Ashcraft E, Adams P, Stratta R. Surveillance pancreas biopsies in solitary pancreas transplantation: a shot in the dark? [abstract]. Xenotransplantation. 2007;14(5):413.

Rogers J, Singh RP, Farney AC, Hartmann EL, Reeves-Daniel A, Doares W, Ashcraft E, Adams PL, Stratta RJ. Does pre-transplant C-peptide level determine outcomes in simultaneous kidney-pancreas transplantation? [abstract]. Xenotransplantation. 2007;14(5):528-529.

Singh RP, Rogers J, Farney AC, Moore PS, Hartmann EL, Reeves-Daniel A, Adams PL, Gautreaux M, Stratta RJ. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage [abstract]. Xenotransplantation. 2007;14(5):414.

Singh RP, Farney AC, Rogers J, Ashcraft E, Hart L, Doares W, Hartmann EL, Reeves-Daniel A, Adams PL, Stratta RJ. Analysis of bacteremia after pancreas transplantation with enteric drainage [abstract]. Xenotransplantation. 2007;14(5):532.

Moore PS, Farney AC, Hartmann EL, Rogers J, Doares W, Gautreaux MD, Iskandar SS, Hairston G, Adams PL, Stratta RJ. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery. 2007;142(4):514-523.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Evolving criteria for accepting deceased donor kidneys for transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):38.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Expanded versus standard criteria donors in kidney transplantation: does age matching make a difference? [abstract]. Transpl Int. 2007;20(Suppl 2):106.

Singh R, Moore P, Farney A, Rogers J, Hartmann E, Reeves-Daniel A, Gautreaux M, Iskandar S, Adams P, Stratta R. Multivariate analysis of risk factors for graft loss in expanded versus standard criteria deceased donors in kidney transplantation [abstract]. Transpl Int. 2007;20(Suppl 2):244.

Stratta R, Moore P, Farney A, Rogers J, Hartmann E, Gautreaux M, Adams P. Does recipient age make a difference in pancreas transplantation? [abstract]. Transpl Int. 2007;20(Suppl 2):310.

Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Kizilisik AT, Hathaway DK, Gaber LW, Gaber AO. Experience with portal-enteric pancreas transplantation at the University of Tennessee Memphis In: Corry RJ, Shapiro R, eds. Pancreatic transplantation. New York: Informa Healthcare;2007: 359-390.

Gaber LW, Egidi MF, Stratta RJ, Lo A, Moore LW, Gaber AO. Clinical utility of histological features of polyomavirus allograft nephropathy. Transplantation. 2006;82(2):196-204.

Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Anderson TK, Adams PL, Stratta RJ, et al. Experience with dual kidney transplants from donors at the extremes of age. Surgery. 2006;140(4):597-606.

Kiger DF, Stratta R, Farney A, Rogers J, Hartmann E, Gautreaux MD. Transplantation may increase risk for Guillain-Barre Syndrome through donor-specific HLA expression [abstract]. Hum Immunol. 2006;67(Suppl 1):S153.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgery, General

Clinical Specialties

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, Transplant Immunology, Organ Preservation and Procurement, Transplant Immunosuppression, General Surgery, Transplant Surgery

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.